These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exploring the Role of N Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789 [TBL] [Abstract][Full Text] [Related]
3. N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors. Roelen H; Veldman N; Spek AL; von Frijtag Drabbe Künzel J; Mathôt RA; IJzerman AP J Med Chem; 1996 Mar; 39(7):1463-71. PubMed ID: 8691477 [TBL] [Abstract][Full Text] [Related]
4. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice. Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449 [TBL] [Abstract][Full Text] [Related]
5. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors. Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575 [TBL] [Abstract][Full Text] [Related]
6. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor. van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026 [TBL] [Abstract][Full Text] [Related]
7. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor. Trivedi BK; Bristol JA; Bruns RF; Haleen SJ; Steffen RP J Med Chem; 1988 Jan; 31(1):271-3. PubMed ID: 3336027 [TBL] [Abstract][Full Text] [Related]
8. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors. Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244 [TBL] [Abstract][Full Text] [Related]
9. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125 [TBL] [Abstract][Full Text] [Related]
10. 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes. Wanner MJ; Von Frijtag Drabbe Künzel JK; Ijzerman AP; Koomen GJ Bioorg Med Chem Lett; 2000 Sep; 10(18):2141-4. PubMed ID: 10999489 [TBL] [Abstract][Full Text] [Related]
11. New 2,N6-disubstituted adenosines: potent and selective A1 adenosine receptor agonists. Hutchinson SA; Baker SP; Scammells PJ Bioorg Med Chem; 2002 Apr; 10(4):1115-22. PubMed ID: 11836122 [TBL] [Abstract][Full Text] [Related]
12. 8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor. Van der Wenden EM; Hartog-Witte HR; Roelen HC; von Frijtag Drabbe Künzel JK; Pirovano IM; Mathôt RA; Danhof M; Van Aerschot A; Lidaks MJ; IJzerman AP Eur J Pharmacol; 1995 Aug; 290(3):189-99. PubMed ID: 7589213 [TBL] [Abstract][Full Text] [Related]
13. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Nakamura I; Ohta Y; Kemmotsu O Anesthesiology; 1997 Sep; 87(3):577-84. PubMed ID: 9316963 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Bruns RF; Lu GH; Pugsley TA Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074 [TBL] [Abstract][Full Text] [Related]
15. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. Cristalli G; Volpini R; Vittori S; Camaioni E; Monopoli A; Conti A; Dionisotti S; Zocchi C; Ongini E J Med Chem; 1994 May; 37(11):1720-6. PubMed ID: 8201607 [TBL] [Abstract][Full Text] [Related]
16. Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline. Appel S; Mathôt RA; Langemeijer MW; IJzerman AP; Danhof M Br J Pharmacol; 1995 Aug; 115(7):1253-9. PubMed ID: 7582553 [TBL] [Abstract][Full Text] [Related]
17. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP; Curtis AR; Kendall DA; Hill SJ Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308 [TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884 [TBL] [Abstract][Full Text] [Related]